Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time

Vox Sanguinis

Volumn 112, Issue 1, 2017, Pages 18-24

  Garner, S F ^a,b   Furnell, A ^a,b   Kahan, B C ^c   Jones, C I ^d   Attwood, A ^a,b   Harrison, P ^e   Kelly, A M ^a,b   Goodall, A H ^f,g   Cardigan, R ^a,b   Ouwehand, W H ^a,b,h  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF READING   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g GLENFIELD HOSPITAL   (United Kingdom)

^h WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

donors; platelet components; platelet function

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; CROSS LINKED COLLAGEN RELATED PEPTIDE; FIBRINOGEN; PADGEM PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; COLLAGEN-RELATED PEPTIDE; PEPTIDE; PROTEIN BINDING;

ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; PATIENT SELECTION; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; TIME; BLOOD CLOTTING PARAMETERS; CHEMISTRY; CYTOLOGY; METABOLISM; PHYSIOLOGY;

ADENOSINE DIPHOSPHATE; ADULT; BLOOD DONORS; BLOOD PLATELETS; CARRIER PROTEINS; COHORT STUDIES; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PEPTIDES; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; PROTEIN BINDING;

EID: 85007378934     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12468     Document Type: Article

References (25)

1. Fontana P, Dupont A, Gandrille S, et al.: Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003; 108:989–995
2. Hetherington SL, Singh RK, Lodwick D, et al.: Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol 2005; 25:252–257
3. Jones CI, Garner SF, Angenent W, et al.: Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost 2007; 5:1756–1765
4. Panzer S, Hocker L, Koren D: Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Ann Hematol 2006; 85:121–125
5. Yee DL, Sun CW, Bergeron AL, et al.: Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 2005; 106:2723–2729
6. Eicher JD, Xue L, Ben-Shlomo Y, et al.: Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS). J Thromb Thrombolysis 2016; 41:343–350
7. Johnson AD, Yanek LR, Chen MH, et al.: Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010; 42:608–613
8. Jones CI, Bray S, Garner SF, et al.: A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 2009; 114:1405–1416
9. O'Donnell CJ, Larson MG, Feng D, et al.: Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation 2001; 103:3051–3056
10. Gieger C, Radhakrishnan A, Cvejic A, et al.: New gene functions in megakaryopoiesis and platelet formation. Nature 2011; 480:201–208
11. Soranzo N, Rendon A, Gieger C, et al.: A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood 2009; 113:3831–3837
12. Soranzo N, Spector TD, Mangino M, et al.: A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41:1182–1190
13. Tofler GH, Brezinski D, Schafer AI, et al.: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316:1514–1518
14. Jaitner J, Stegherr J, Morath T, et al.: Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patients. Thromb Haemost 2011; 105:107–112
15. Garner SF, Jones CI, Stephens J, et al.: Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality. Transfusion 2008; 48:673–680
16. Jimenez TM, Patel SB, Pineda AA, et al.: Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion 2003; 43:328–334
17. Jilma-Stohlawetz P, Hergovich N, Homoncik M, et al.: Impaired platelet function among platelet donors. Thromb Haemost 2001; 86:880–886
18. Knight CG, Morton LF, Onley DJ, et al.: Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res 1999; 41:450–457
19. Bray PF, Mathias RA, Faraday N, et al.: Heritability of platelet function in families with premature coronary artery disease. J Thromb Haemost 2007; 5:1617–1623
20. Miller CH, Rice AS, Garrett K, et al.: Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results. Br J Haematol 2014; 165:842–853
21. Peace AJ, Egan K, Kavanagh GF, et al.: Reducing intra-individual variation in platelet aggregation: implications for platelet function testing. J Thromb Haemost 2009; 7:1941–1943
22. Hagberg IA, Akkok CA, Lyberg T, et al.: Apheresis-induced platelet activation: comparison of three types of cell separators. Transfusion 2000; 40:182–192
23. Perseghin P, Mascaretti L, Speranza T, et al.: Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators. Transfusion 2004; 44:125–130
24. Rinder HM, Murphy M, Mitchell JG, et al.: Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991; 31:409–414
25. Dijkstra-Tiekstra MJ, Pietersz RN, Huijgens PC: Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters. Vox Sang 2004; 87:257–263